Skip to main content

n-6 Fatty acids and nervous system disorders

  • Chapter
Medicinal Fatty Acids in Inflammation

Part of the book series: Progress in Inflammation Research ((PIR))

  • 96 Accesses

Abstract

The relationship between n-6 essential fatty acids (EFAs) and nervous system disorders is a subject of emerging interest. In one specific area, the peripheral neuropathy of diabetes, the role of n-6 EFAs is now well established. In other areas, including schizophrenia and dyskinesias, much less work has been done although there is tantalising evidence that n-6 EFAs may be involved. This review will primarily concentrate on diabetic neuropathy with a short section drawing attention to the few key papers in these disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Peifer JJ, Holman RT (1955) Essential fatty acids, diabetes and cholesterol. Arch Biochem Biophys 57: 520–521

    Article  PubMed  CAS  Google Scholar 

  2. Mercuri O, Peluffo RO, Brenner RR (1966) Depression of microsomal desaturation of linoleic to gamma-linolenic acid in the alloxan diabetic rat. Biochim Biophys Acta 116: 407–411

    Article  Google Scholar 

  3. Brenner RR (1982) Nutritional and hormonal factors influencing desaturation of essen-tial fatty acids. Progr Lipid Res 20: 41–48

    Article  Google Scholar 

  4. Horrobin DF (1992) Nutritional and medical importance of gamma-linolenic acid. Progr Lipid Res 31: 163–194

    Article  CAS  Google Scholar 

  5. Horrobin DF (1988) The roles of essential fatty acids in the development of diabetic neuropathy and other complications of diabetes mellitus. Prostaglandins, Leukotr Essential Fatty Acids 31: 181–197

    CAS  Google Scholar 

  6. Horrobin DF (ed) (1992) Treatment of Diabetic Neuropathy: A New Approach. Churchill Livingstone, Edinburgh and New York

    Google Scholar 

  7. Jamal GA (1994) The use of gamma linolenic acid in the prevention and treatment of diabetic neuropathy. Diabetic Med 11: 145–149

    Article  PubMed  CAS  Google Scholar 

  8. Horrobin DF, Durand LG, Manku MS (1977) Prostaglandin E1 modifies nerve conduc-tion and interferes with local anaesthetic action. Prostaglandins 14: 103–110

    Article  PubMed  CAS  Google Scholar 

  9. Julu POO (1988) Essential fatty acids prevent slowed nerve conduction velocity in strep-tozotocin diabetes rats. J Diabetic Comp 2: 185–188

    Article  CAS  Google Scholar 

  10. Julu POO (1992) Responses of peripheral nerve conduction velocities to treatment with essential fatty acids in diabetic rats: possible mechanisms of action. In: DF Horrobin (ed): Treatment of diabetic neuropathy: a new approach. Churchill Livingstone, Edinburgh and New York, 41–62

    Google Scholar 

  11. Tomlinson DR, Robinson JP, Compton AM, Keen P (1989) Essential fatty acid treatment - effects on nerve conduction, polyol pathway and axonal transport in streptozotocin diabetic rats. Diabetologia 32: 655–659

    Article  PubMed  CAS  Google Scholar 

  12. Stevens EJ, Lockett MJ, Carrington AL, Tomlinson DR (1993) Essential fatty acids treatment prevents nerve ischaemia and associated conduction anomalies in rats with experimental diabetes mellitus. Diabetologia 36: 397–401

    Article  PubMed  CAS  Google Scholar 

  13. Stevens EJ, Carrington AL, Tomlinson DR (1993) Prostacyclin release in experimental diabetes: effects of evening primrose oil. Prostaglandins Leukotr Essential Fatty Acids 49: 699–706

    Article  CAS  Google Scholar 

  14. Cameron NE, Cotter MA, Robertson S (1991) Essential fatty acid diet supplementation. Effects on peripheral nerve and skeletal muscle function and capillarization in streptozocin-induced diabetic rats. Diabetes 40: 532–539

    Article  PubMed  CAS  Google Scholar 

  15. Dines KC, Cotter MA, Cameron NE (1993) Contrasting effects of treatment with ω-3 and ω-6 essential fatty acids on peripheral nerve function and capillarization in streptozotocin-diabetic rats. Diabetologia 36: 1132–1138

    Article  PubMed  CAS  Google Scholar 

  16. Cameron NE, Cotter MA (1993) Potential therapeutic approaches to the treatment or prevention of diabetic neuropathy: evidence from experimental studies. Diabetic Med 10: 593–605

    Article  PubMed  CAS  Google Scholar 

  17. Omawari N, Mahmood S, Dewhurst M, Stevens EJ, Tomlinson DR (1995) Deficient nitric oxide is responsible for reduced nerve blood flow in diabetic rats: prevention by essential fatty acids. Br J Pharmacol 116: 63

    Google Scholar 

  18. Redden PR, Lin XR, Fahey J, Horrobin DF (1995) Stereospecific analysis of the major triacylglycerol species containing gamma-linolenic acid in evening primrose oil and borage oil. J Chromatography 704: 99–111

    Article  CAS  Google Scholar 

  19. Dines KC, Cameron NE, Cotter MA (1995) Comparison of the effects of evening primrose oil and triglycerides containing γ-linolenic acid on nerve conduction and blood flow in diabetic rats. J Pharmacol Exp Ther 273: 49–55

    PubMed  CAS  Google Scholar 

  20. Dines KC Cotter MA, Cameron NE (1996) Effectiveness of natural oils as sources of gamma-linolenic acid to correct peripheral nerve conduction velocity abnormalities in diabetic rats: modulation by thromboxane A2 inhibition. Prostaglandins Leukotr Essent Fatty Acids 55: 159–165

    Article  CAS  Google Scholar 

  21. Dines KC (1994) Effects of oils containing gamma-linolenic acid on nerve function in diabetic rats. PhD Thesis, University of Aberdeen

    Google Scholar 

  22. Jenkins DK, Mitchell JC, Manku MS, Horrobin, DF (1988) Effects of different sources of gamma-linolenic acid on the formation of essential fatty acid and prostanoid metabolites. Med Sci Res 16: 525–526

    CAS  Google Scholar 

  23. Fan Y-Y, Chapkin RS (1992) Mouse peritoneal macrophage prostaglandin E1 synthesis is altered by dietary gamma-linolenic acid. J Nutr 122: 1600–1606

    PubMed  CAS  Google Scholar 

  24. Horrobin DF (1994) Natural does not equal safe. Pharmaceutical Tech Europe, December 14–15

    Google Scholar 

  25. Van Doormaal JJ, Idema IG, Muskiet FAJ, Martini IA, Doorenbos H (1988) Effects of short-term high dose intake of evening primrose oil on plasma and cellular fatty acid compositions, a-tocopherol levels, and erythropoiesis in normal and Type I (insulin-dependent) diabetic men. Diabetologia 31: 576–584

    Article  PubMed  Google Scholar 

  26. Tilvis RS, Miettinen TA (1985) Fatty acid composition of serum lipids erythrocytes and platelets in insulin-dependent diabetic women. J Clin Endocr Metabol 61: 741–745

    Article  CAS  Google Scholar 

  27. Arisaka M, Arisaka O, Fukuda Y, Yamashiro Y (1986) Prostaglandin metabolism in children with diabetes mellitus. I. Plasma prostaglandin E2, F2a, TxB2 and serum fatty acid levels. J Paed Gastroenterol Nutr 5: 878–882

    Article  CAS  Google Scholar 

  28. Horrobin DF (1997) Essential fatty acid metabolism in patients with diabetic neuropathy. Prostaglandins Leukotr EFAs 57: 256

    Google Scholar 

  29. Jamal GA, Carmichael H (1990) The effect of y linolenic acid on human diabetic peripheral neuropathy: a double-blind placebo-controlled trial. Diabetic Med 7: 319–323

    Article  PubMed  CAS  Google Scholar 

  30. The Gamma-linolenic Acid Multicenter Trial Group (1993) Treatment of diabetic neuropathy with y-linolenic acid. Diabetes Care 16: 8–15

    Article  Google Scholar 

  31. Gamma-linolenic Acid Multicenter Trial Group (Boulton AJ) (1997) Two multicentre double blind trials of gamolenic acid in diabetic peripheral sensori motor neuropathy. Prostaglandins Leukotr EFAs 57: 201

    Google Scholar 

  32. Horrobin DF Glen AI, Vaddadi K (1994) The membrane hypothesis of schizophrenia. Schizophr Res 13: 195–207

    Article  PubMed  CAS  Google Scholar 

  33. Mahhadik SP, Gowda S (1996) Antioxidants in the treatment of schizophrenia. Drugs Today 32: 553–565

    Google Scholar 

  34. Ward P, Sutherland J, Glen E, Glen I (1998) Niacin skin flush in schizophrenia. Schizophr Res 29: 269–274

    Article  PubMed  CAS  Google Scholar 

  35. Nilsson A, Horrobin DF, Rosengren A, Waller L, Adlerberth A, Wilhelmsen L (1996) Essential fatty acids and abnormal involuntary movements in the general male population: a study of men born in 1933. Prostaglandins Leukotr EFAs 55: 83–87

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Basel AG

About this chapter

Cite this chapter

Horrobin, D.F. (1998). n-6 Fatty acids and nervous system disorders. In: Kremer, J.M. (eds) Medicinal Fatty Acids in Inflammation. Progress in Inflammation Research. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8825-7_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-8825-7_5

  • Publisher Name: Birkhäuser, Basel

  • Print ISBN: 978-3-0348-9788-4

  • Online ISBN: 978-3-0348-8825-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics